DOP2009000057A - COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS - Google Patents

COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS

Info

Publication number
DOP2009000057A
DOP2009000057A DO2009000057A DO2009000057A DOP2009000057A DO P2009000057 A DOP2009000057 A DO P2009000057A DO 2009000057 A DO2009000057 A DO 2009000057A DO 2009000057 A DO2009000057 A DO 2009000057A DO P2009000057 A DOP2009000057 A DO P2009000057A
Authority
DO
Dominican Republic
Prior art keywords
compounds
compositions
protein inhibitors
abl
abnormal
Prior art date
Application number
DO2009000057A
Other languages
Spanish (es)
Inventor
Pamela A Albaugh
Gregory S Chopiuk
Qiang Ding
Shenlin Huang
Zuosheng Liu
Shifeng Pan
Pingda Ren
Xia Wang
Xing Wang
Yongping Xie
Chengzhi Zhang
Qiong Zhang
Guobao Zhang
Daniel Poon
Paul Renhowe
Martin Sendzik
Original Assignee
Novartis Ag
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Irm Llc filed Critical Novartis Ag
Priority to DO2009000057A priority Critical patent/DOP2009000057A/en
Publication of DOP2009000057A publication Critical patent/DOP2009000057A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona una nueva clase de compuestos, composiciones farmaceuticas que comprenden dichos compuestos y método para utilizar estos compuestos para tratar o prevenir enfermedades o trastornos asociados con la actividad anormal o irregular de la cinasa, particularmente, enfermedades o trastornos que involucran la activación anormal de las cinasas Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-r, b-Raf, SAPK2, Src, Tie2 y TrKB.The invention provides a new class of compounds, pharmaceutical compositions comprising said compounds and method for using these compounds to treat or prevent diseases or disorders associated with the abnormal or irregular activity of the kinase, particularly, diseases or disorders that involve the abnormal activation of Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-r, b-Raf, SAPK2, Src, Tie2 and TrKB kinases.

DO2009000057A 2009-04-01 2009-04-01 COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS DOP2009000057A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2009000057A DOP2009000057A (en) 2009-04-01 2009-04-01 COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2009000057A DOP2009000057A (en) 2009-04-01 2009-04-01 COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS

Publications (1)

Publication Number Publication Date
DOP2009000057A true DOP2009000057A (en) 2009-04-30

Family

ID=44261560

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2009000057A DOP2009000057A (en) 2009-04-01 2009-04-01 COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS

Country Status (1)

Country Link
DO (1) DOP2009000057A (en)

Similar Documents

Publication Publication Date Title
CR10670A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN QUINASA
GT201400036A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE C - KIT
CU20140024A7 (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE c-Kit
NI201200029A (en) COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
MX2014002486A (en) Compounds and compositions as pdgfr kinase inhibitors.
ECSP099378A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN QUINASA
MX2009011951A (en) Compounds and compositions as c-kit and pdgfr kinase inhibitors.
CU20130115A7 (en) COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
BRPI0811617A2 (en) primidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
EA201001331A1 (en) HETEROCYCLIC COMPOUNDS AND CONTAINING THEIR COMPOSITIONS AS AN INHIBITORS KINAZ c-kit AND PDGFR
MX2015005536A (en) Treatment of cancers using pi3 kinase isoform modulators.
UY33597A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK
MY169987A (en) Selective pi3k delta inhibitors
UA111075C2 (en) Triazolopyridine compounds as pim kinase inhibitors
NI201000194A (en) HETEROCYCLES CONTAINING FUSED NITROGEN AND COMPOSITIONS THEREOF AS KINASE INHIBITORS.
EA201490537A1 (en) COMPOUNDS AND COMPOSITIONS AS A K-KAZASE INHIBITOR C-Kit
BR112014003963A2 (en) compounds and compositions as c-kit kinase inhibitors
MX2009011952A (en) Compounds and compositions as c-kit and pdgfr kinase inhibitors.
DOP2009000057A (en) COMPOUNDS AND COMPOSITIONS AS PROTEIN INHIBITORS
AR122753A2 (en) SELECTIVE INHIBITORS OF DELTA PI3K PROTEIN KINASES, PHARMACEUTICAL COMPOSITIONS, USES, AND METHODS OF TREATMENT AND/OR PREVENTION OF DISEASES OR DISORDERS MEDIATED BY KINASES